World's Best Scientists 2026 revealed!
Fabrice Carrat

Fabrice Carrat

D-Index & Metrics

Microbiology

D-Index
84
Citations
25901
World Ranking
921
National Ranking
51

Medicine

D-Index
87
Citations
31058
World Ranking
13555
National Ranking
429

Overview

Fabrice Carrat is affiliated with Université Paris Cité in France, with a primary focus on Medicine. Their research spans several subfields including Epidemiology, Infectious Diseases, Hepatology, Clinical Psychology, and Neurology.

The main topics covered in their work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and Mental Health
  • Long-Term Effects of COVID-19
  • COVID-19 epidemiological studies

Fabrice Carrat has contributed to several recent papers, including the following:

  • Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients*, 2021, British Journal of Dermatology
  • Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic, 2021, JAMA Internal Medicine
  • Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France, 2021, The Lancet Regional Health - Europe
  • Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis, 2021, Journal of Hepatology
  • Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts, 2020, Liver International

The scientist frequently publishes in venues such as:

  • Journal of Hepatology
  • Influenza and Other Respiratory Viruses
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Liver International

Fabrice Carrat has collaborated extensively with several co-authors over their career. Frequent co-authors include:

  • Mathilde Touvier
  • Marie Zins
  • Céline Dorival
  • Stanislas Pol
  • Gianluca Severi

Best Publications

  • Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies

    Fabrice Carrat;Fabrice Carrat;Elisabeta Vergu;Elisabeta Vergu;Elisabeta Vergu;Neil M. Ferguson;Magali Lemaitre;Magali Lemaitre

  • Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

    Laurent Beaugerie;Nicole Brousse;Anne Marie Bouvier;Jean Frédéric Colombel

  • Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

  • Influenza vaccine: the challenge of antigenic drift.

    Fabrice Carrat;Antoine Flahault;Antoine Flahault

  • Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

    David Saadoun;Michelle Rosenzwajg;Florence Joly;Adrien Six

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

    Laurent Peyrin–Biroulet;Kiarash Khosrotehrani;Fabrice Carrat;Anne–Marie Bouvier

  • Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.

    Magali Lemaitre;Julien Kirchgesner;Annie Rudnichi;Fabrice Carrat

  • Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

    Julien Kirchgesner;Magali Lemaitre;Fabrice Carrat;Mahmoud Zureik

  • Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890

    Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey

  • A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data.

    S. Cauchemez;F. Carrat;C. Viboud;C. Viboud;A. J. Valleron

  • The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.

    Christophe Corpechot;Fabrice Carrat;Abbas Bahr;Yves Chrétien

  • Risk factors of influenza transmission in households

    Cécile Viboud;Pierre-Yves Boëlle;Simon Cauchemez;Audrey Lavenu

  • Liver biopsy: the best, not the gold standard.

    Pierre Bedossa;Fabrice Carrat

  • The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

    Christophe Corpechot;Fabrice Carrat;Anne Marie Bonnand;Renée Eugénie Poupon

  • Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

    Christophe Corpechot;Fabrice Carrat;Armelle Poujol-Robert;Farid Gaouar

  • Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

    Laurent Beaugerie;Magali Svrcek;Philippe Seksik;Anne–Marie Bouvier

  • Further characterization of clinical and laboratory features occurring in VEXAS syndrome in a large-scale analysis of multicenter case-series of 116 French patients

    S. Georgin-Lavialle;B. Terrier;A.F. Guedon;M. Heiblig

  • Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.

    Christophe Corpechot;Farid Gaouar;Ahmed El Naggar;Astrid Kemgang

  • Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

    Christophe Hézode;Helene Fontaine;Celine Dorival;Fabien Zoulim

  • Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

Frequent Co-Authors

Stanislas Pol
Stanislas Pol Université Paris Cité
Patrice Cacoub
Patrice Cacoub Sorbonne University
Pierre-Yves Boëlle
Pierre-Yves Boëlle Sorbonne University
Dominique Larrey
Dominique Larrey University of Montpellier
Olivier Chazouillères
Olivier Chazouillères Université Paris Cité
Olivier Fain
Olivier Fain Université Paris Cité
Karine Lacombe
Karine Lacombe Hôpital Saint-Antoine
Laurent Alric
Laurent Alric Federal University of Toulouse Midi-Pyrénées
Christophe Hézode
Christophe Hézode Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various allied health and science careers. For those interested in healthcare administration, exploring health information management job description and salary can provide insight into a growing field that combines biology knowledge with data management.

Many professionals in related healthcare roles start with a certificate or associate degree. Programs like the fastest online medical billing and coding certificate programs offer flexible pathways to quickly enter the workforce, often leading to certifications like the Certified Professional Coder (CPC). Understanding the cpc medical coding salary and career paths helps in evaluating this option.

For those aiming for more advanced roles, earning a degree from cahiim accredited health information management programs online can be crucial. These programs ensure industry standards compliance and facilitate career advancement in health data management and analysis.

Overall, combining microbiology expertise with health information and coding skills presents diverse and rewarding career opportunities in the evolving healthcare landscape.

Best Scientists Citing Fabrice Carrat

Trending Scientists